In contrast to this viewpoint, an article and associated editorial in the New England Journal of Medicine in May 2015 emphasized the importance of pharmaceutical industry-physician interactions for the development of novel treatments, and argued that moral outrage over industry malfeasance had unjustifiably led many to overemphasize the problems created by financial conflicts of interest. The article noted that major healthcare organizations such as National Center for Advancing Translational Sciences of the National Institutes of Health, the President’s Council of Advisors on Science and Technology, the World Economic Forum, the Gates Foundation, the Wellcome Trust, and the Food and Drug Administration had encouraged greater interactions between physicians and industry in order to bring greater benefits to patients. COUNT 8
QSN1 Who were some of the companies that encouraged the interactions between doctors and the pharmaceutical industry? ANS1 World Economic Forum, the Gates Foundation, the Wellcome Trust, and the Food and Drug Administration QSN2 When did the article come out about the importance of interactions? ANS2 May 2015 QSN3 What was the reason behind these interactions? ANS3 bring greater benefits to patients QSN4 What was believed to have created a financial conflict of interest? ANS4 moral outrage over industry malfeasance QSN5 Who printed the article about the importance of interactions? ANS5 New England Journal of Medicine QSN6 What publication had an article about the importance of pharmaceutical industry-physician interactions in 2015? ANS6 New England Journal of Medicine QSN7 When was the editorial published? ANS7 May 2015 QSN8 Did major healthcare organizations support or discourage interactions between doctors and industries? ANS8 encouraged greater interactions